-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
RECURSION PHARMACEUTICALS, INC. quarterly/annual Nonoperating Income (Expense) history and change rate from 2019 to Q3 2025.
- RECURSION PHARMACEUTICALS, INC. Nonoperating Income (Expense) for the quarter ending 30 Sep 2025 was $9.95M, a 271% increase year-over-year.
- RECURSION PHARMACEUTICALS, INC. Nonoperating Income (Expense) for the twelve months ending 30 Sep 2025 was $7.87M, a 29.8% decline year-over-year.
- RECURSION PHARMACEUTICALS, INC. annual Nonoperating Income (Expense) for 2024 was $14.2M, a 20.7% decline from 2023.
- RECURSION PHARMACEUTICALS, INC. annual Nonoperating Income (Expense) for 2023 was $17.9M, a 187% increase from 2022.
- RECURSION PHARMACEUTICALS, INC. annual Nonoperating Income (Expense) for 2022 was $6.25M.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Change (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Change (%)